Fermenta Biotech Limited (BOM:506414)
India · Delayed Price · Currency is INR 447.05
+30.40 (7.30%)
At close: Nov 6, 2026
Fermenta Biotech Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 5,067 | 5,254 | 4,695 | 3,357 | 3,499 | 3,985 |
Revenue Growth | -9.97% | 11.92% | 39.87% | -4.08% | -12.19% | 5.63% |
Gross Profit Gross Profit Growth | 2,963 | 3,112 | 2,851 | 1,822 | 1,801 | 2,315 |
Operating Income Operating Income Growth | 554.95 | 781.37 | 905.42 | 31.17 | -103.27 | 359.77 |
Net Income Net Income Growth | 505.61 | 717.65 | 768.62 | -230.6 | -510.75 | 154.47 |
Earnings Per Share EPS Growth | 17.30 | 24.51 | 26.35 | -7.99 | -17.70 | 5.33 |
EPS Growth | -54.65% | -6.98% | - | - | - | -66.03% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Bulk Drugs/chemicals Bulk Drugs/chemicals Growth | 4,982 | 5,147 | 4,005 | 2,592 | 2,796 | 3,853 |
Property Property Growth | 79.54 | 95.13 | 544.02 | 737.42 | 630.34 | 166 |
Unallocated Unallocated Growth | 228.07 | 235.8 | 264.06 | 145.2 | 159.22 | - |
Total Total Growth | 5,290 | 5,478 | 4,813 | 3,475 | 3,585 | 4,017 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 591.09 | 327.58 | 706.59 | 598.24 | 600.59 | 256.93 |
Total Debt Total Debt Growth | 1,086 | 1,133 | 1,149 | 1,388 | 2,195 | 2,392 |
Net Cash (Debt) Net Cash Growth | -494.73 | -805.71 | -442.76 | -789.44 | -1,595 | -2,135 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -16.93 | -27.52 | -15.18 | -27.34 | -55.26 | -73.61 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 1,096 | 928.34 | 409.02 | 1,053 | 1,161 | 434.41 |
Capital Expenditures CapEx Growth | -352.28 | -303.35 | -221.33 | -192.07 | -404.89 | -371.28 |
Free Cash Flow Free Cash Flow Growth | 743.55 | 624.99 | 187.69 | 861.39 | 756.19 | 63.13 |
Free Cash Flow Growth | 41.24% | 233.00% | -78.21% | 13.91% | 1097.83% | -13.83% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 58.48% | 59.23% | 60.72% | 54.29% | 51.47% | 58.09% |
Operating Margin | 10.95% | 14.87% | 19.29% | 0.93% | -2.95% | 9.03% |
Pretax Margin | 14.33% | 18.24% | 17.72% | -2.94% | -14.66% | 6.76% |
Profit Margin | 9.98% | 13.66% | 16.37% | -6.87% | -14.59% | 3.88% |
FCF Margin | 14.67% | 11.89% | 4.00% | 25.66% | 21.61% | 1.58% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 7, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 3.750 | 3.750 | 2.500 | 1.250 | 1.250 | 1.250 |
Dividend Per Share Growth | 50.00% | 50.00% | 100.00% | 0% | 0% | -50.00% |
Dividend Yield | 0.84% | 1.15% | 0.91% | 0.84% | 1.17% | 0.61% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 7, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 25.84 | 13.08 | 10.47 | - | - | 38.41 |
Forward PE | - | 12.25 | 12.25 | 12.25 | 12.25 | 12.25 |
P/FCF Ratio | 17.24 | 15.02 | 42.90 | 5.08 | 4.08 | 94.00 |
PS Ratio | 2.53 | 1.79 | 1.72 | 1.30 | 0.88 | 1.49 |